Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,022 | 0,034 | 08:51 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
14.05. | Stagezero Life Sciences Ltd (2): Stagezero, ElevationMD use Aristotle to detect cancer | 1 | Stockwatch | ||
STAGEZERO LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
13.05. | StageZero Life Sciences Ltd.: StageZero Life Sciences and ElevationMD Introduce Aristotle and AVRT for the Early Detection of Cancer | 3 | TheNewswire | ||
07.05. | StageZero Life Sciences Ltd.: StageZero Announces Partial Revocation of Cease Trade Order and Proposed Financing | 4 | TheNewswire |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CARL ZEISS MEDITEC | 50,70 | -1,93 % | ANALYSE-FLASH: RBC lässt Carl Zeiss Meditec auf 'Sector Perform' - Ziel 60 Euro | NEW YORK (dpa-AFX) - Die kanadische Bank RBC hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 60 Euro auf "Sector Perform" belassen. Analyst Jack Reynolds-Clark sieht laut seinem am... ► Artikel lesen | |
INTUITIVE SURGICAL | 443,85 | +0,51 % | Opening Bell: Block, Alphabet, Tesla, NextEra Energy, Intuitive Surgical, Constellation Energy | Nachdem die US-Börsen am Freitag zunächst knapp neue Rekordstände erreicht hatten, gaben die Kurse im weiteren Verlauf nach und schlossen weitgehend unverändert. Sowohl der S&P 500 als auch die Nasdaq... ► Artikel lesen | |
BOSTON SCIENTIFIC | 89,20 | +0,22 % | Raymond James maintains Strong Buy on Boston Scientific stock | ||
PLUS THERAPEUTICS | 0,384 | 0,00 % | PLUS THERAPEUTICS, INC. - 8-K, Current Report | ||
EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
LIFEWARD | 0,738 | 0,00 % | Lifeward Ltd.: Administrative Law Judge Determines ReWalk Personal Exoskeleton is "Reasonable and Necessary" for Medicare Beneficiary | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
SENSEONICS | 0,489 | -1,17 % | Senseonics stock initiated with Buy rating at Lake Street Capital | ||
EKSO BIONICS | 3,960 | 0,00 % | Ekso Bionics Holdings, Inc.: Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country | ||
IMUNON | 0,490 | +2,51 % | Imunon, Inc.: IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan | Management provides Nasdaq Hearing Panel with a comprehensive executable plan for long term compliance LAWRENCEVILLE, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage... ► Artikel lesen | |
ROCKWELL MEDICAL | 0,950 | -1,76 % | Rockwell Medical signs multi-year supply agreement with Innovative Renal Care | ||
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
MEMPHASYS | 0,002 | 0,00 % | XFRA IG7: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
VIRIDIAN THERAPEUTICS | 14,400 | +0,24 % | Viridian Therapeutics, Inc.\DE - 8-K, Current Report | ||
SINTX TECHNOLOGIES | 2,790 | 0,00 % | SINTX Technologies, Inc.: SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors | New leadership and recapitalization to accelerate commercialization of proprietary silicon nitride technologies in medical and high-growth markets SALT LAKE CITY, Utah, June 12, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
PREDICTIVE ONCOLOGY | 0,785 | 0,00 % | Predictive Oncology Inc.: Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx and Pursuit of Other High-Value AI-Driven Drug Discovery and Development ... | $10 million securities purchase agreement provides efficient and flexible funding in support of strategic multi-million dollar growth initiatives Discussions underway to expand adoption of ChemoFx... ► Artikel lesen |